Abstract:ObjectiveTo construct a recombinant Listeria ivanovii (LI) strain that expressed Mycobacterium tuberculosis (MTB) specific antigen protein as a novel multistage tuberculosis (TB) vaccine candidate, and evaluate the biosafety and immunogenicity in mouse model.MethodsT cell epitopes of four genes related to different stages of MTB infection were fused in series to form an antigen gene, i.e. the multistage antigen gene (named msv). Then msv was inserted into the targeting plasmid that contained LI homologous sequences. Recombinant LI strain was obtained by transfecting LI with targeting plasmid and screening the recombinant LI strain that carried msv in the genome after series of homologous gene recombination processes. The growth rate of the recombinant LI strain in vitro was observed and the expression of target protein was verified by Western blot. The 50% lethal dose (LD 50) of the recombinant strain to C57BL/6 mice was measured. Mice were intravenously inoculated with vaccine candidate in dose of 0.1×LD 50.The serum alanine aminotransferase (ALT) levels, bacterial load in organs, and organ pathological sections before and 1, 2, 3, 5, 7, 14 d after vaccination were used to evaluate the safety of vaccine candidate strain. To analyze the immunogenicity of vaccine candidate strain, mice were intravenously inoculated with LI- msv, LI, and NS respectively. Nine days post immunization, the spleens were isolated under sterile conditions and splenocytes were collected and stimulated. Lyphocytes which secret specific cytokines, interferon (IFN)-γ, tumor necrosis factor (TNF)-α and interleukin (IL)-2 were analyzed by flow cytometry.ResultsA recombinant strain named LI- msv which was capable of expressing the multistage TB antigen protein was successfully constructed. The LD 50 value of LI- msv for C57BL/6 mice (i.v.) was 3.3×10 8 CFU. After intravenously immunized the mice, this strain mainly multiplied in the liver and spleen, and was cleared at 7 d post innoculation. Such infection process caused transient pathological damages of the liver and spleen. Results of flow cytometry showed specific IFN-γ + CD4 + and IFN-γ + CD8 +T lymphocytes were successfully induced in LI -msv immunized mice spleen lymphocytes. The frequency of IFN-γ positive CD4 + and CD8 +T cells was significantly higher than those of vector control group and NS control group ( P<0.005). Additionally, the frequency of specific TNF-α + CD4 + T cell in LI -msv immunized group was significantly higher than that of vector control ( P<0.01) and NS control group ( P<0.005), and TNF-α + CD8 + T cell frequency obviously increased than NS control group ( P<0.005).ConclusionsA novel multistage TB vaccine candidate expressing TB multistage antigen based on LI was successfully constructed. This vaccine candidate is safe and can induce specific cellular immune response to some extent. It is promising to be further studied as a candidate vaccine against tuberculosis.

Study on the High Density Cultivation of Mycobacterium Bovis DNA Vaccine Engineering Bacteria

[Construction and Evaluation of a Tuberculosis Multistage Vaccine Candidate Based on Recombinant Listeria Ivanovii].

Cloning and expression of Mycobacterium bovis secreted protein MPB83 in Escherichia coli.

A novel DNA vaccine for protective immunity against virulent Mycobacterium bovis in mice

High cell density culture of Bacillus 13002

Vaccination Of Mice And Cattle With Plasmid Dna Encoding The Mycobacterium Bovis Antigen Mpb83

Response Surface Methodology to Optimize Fermentation Technology of Brevibacillus brevis ch2-22

The Preparation of Mycobacterium Tuberculosis HSP65 DNA Vaccine and the Prokaryotic Expression of the Recombinant HSP65 Protein

Construction and immunogenicity of DNA vaccine of Ag85A gene of mycobacterium tuberculosis

Expression of Mb2277 of M. Bovis and Initial Research on Its Reactogenicity

Optimization of Fermentation Medium for Production of Antibacterial Peptides by Bacillus Subtilis BSD-2

Inducible Escherichia coli fermentation for increased plasmid DNA production

Expression of Mb1761c of M.bovis and Initial Research on Its Antigenicity

Construction of the MTB41 DNA Vaccine of Mycobacterium Tuberculosis and Its Cloning,Expression in Prokaryotic Expression Vector

Study on High Cell Density Culture of Lactobacillus Acidophilus

Humoral and Cellular Immune Responses Elicited by the Trivalent DNA Vaccine Against Mycobacterium Tuberculosis

Engineering Escherichia coli to increase plasmid DNA production in high cell-density cultivations in batch mode

High-level fed-batch fermentative expression of an engineered Staphylococcal protein A based ligand in E. coli: purification and characterization

Construction method and application of recombinant bacteria for increasing yield of vitamin B12

Improving the Immunogenicity of the Mycobacterium bovis BCG Vaccine by Non-Genetic Bacterial Surface Decoration Using the Avidin-Biotin System

Studies on Cultural Technology of High Expression of the Recombinant Human Gut Growth Hormone in E.coli BL21